MSRT/MassRoots Chairman Isaac Dietrich Presenting at The

New Post Public Reply Private Reply Replies (2) Message Board
4kids 4kids #455
337
MSRT /MassRoots Chairman Isaac Dietrich Presenting at The ArcView Group's Toronto Investor Forum Today at 1:15pm ET


TORONTO, July 17, 2017 /PRNewswire/ -- MassRoots, Inc. (OTCQB: MSRT ), one of the leading technology and compliance platforms for the cannabis industry, is pleased to announce that MassRoots' Chief Executive Officer, Chairman of the Board of Directors, and Largest Shareholder, Mr. Isaac Dietrich, will be presenting at The ArcView Group's Toronto Investor forum at 1:15pm ET today, July 17, 2017 at Toronto Marriott Downtown Eaton Centre, 525 Bay Street, Toronto, Ontario.


Mr. Dietrich is expected to provide an update on MassRoots' recent acquisition of Odava, Inc. and cover the Company's plan to scale its monthly recurring revenue. A copy of the presentation may be accessed here.

Members of the ArcView Group have collectively invested more than $7 million in MassRoots through equity offerings and warrant exercises since first pitching at an ArcView event in September 2013. The ArcView Group's membership of 600 accredited investors has collectively invested $125 million into the leading companies in the cannabis industry.

"MassRoots is one of the most notable companies to present to our investor group and Isaac will now have presented at 14 consecutive ArcView investor forums – more than any other entrepreneur in our history," stated Mr. Troy Dayton, Co-Founder and Chief Executive Officer of the ArcView Group. "ArcView's investor forums bring together the cannabis industry's leading companies and high net worth investors in an intimate two-day forum. If you are investing any significant capital in this space, you might as well leverage the tremendous value of your peers by being an ArcView member."

About MassRoots
MassRoots, Inc. is one of the leading technology platforms for the regulated cannabis industry. Powered by more than one million registered users, the Company's mobile apps empower consumers to make educated cannabis purchasing decisions through community-driven reviews. Its compliance and point-of-sale system, Odava, enables cannabis-related businesses to streamline their retail operations and compliance reporting to state regulators. With a significant market share of medical cannabis patients in certain markets, more than 25,000 shareholders, equity financings and warrant exercises of more than $17 million since inception, the Company believes it is uniquely positioned to best serve the needs of the cannabis industry. For more information, please visit MassRoots.com/Investors and MassRoots, Inc.'s filings with the U.S. Securities and Exchange Commission.

Forward-looking Statements
Certain matters discussed in this announcement contain statements, estimates and projections about the growth of MassRoots, Inc.'s business, partnerships, new features, acquisitions, user growth and related business strategy. Such statements, estimates and projections may constitute forward-looking statements within the meaning of the federal securities laws. Factors or events that could cause our actual results to differ may emerge from time to time. MassRoots undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements. For more information, please refer to MassRoots, Inc.'s filings with the U.S. Securities and Exchange Commission.




View original content with multimedia:http://www.prnewswire.com/news-releases/massroots-chairman-isaac-dietrich-presenting-at-the-arcview-groups-toronto-investor-forum-today-at-115pm-et-300489029.html

SOURCE MassRoots, Inc.

Greenwave Technology Solutions Inc. (GWAV) Stock Research Links

GWAV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

transcosmos Secures Special Jury Award for Outstanding Strategy

Updated Category News Views 157

Transcosmos Achieves Recognition at Contact Center Awards Recognized for clear, goal-oriented strategy working together with clients. TOKYO /PRNewswire/ -- transcosmos is thrilled to share that the company has been awarded the Special Jury Award in the Strategy category at the Contact Center Awards 2025. This prestigious event is sponsored by the Editorial Office of...

Continue Reading
HCW Biologics Partners with WY Biotech for Innovative Licensing Deal

Updated Category News Views 121

HCW Biologics Collaborates with WY Biotech on a Licensing Agreement HCW Biologics has taken an exciting step forward by entering into a license agreement with WY Biotech for a transformative preclinical immunotherapeutic product candidate. This partnership positions both companies to harness innovative technologies in the biopharmaceutical landscape. Financial Aspects of...

Continue Reading
Bucked Up® Unveils Hunt: Orange Cream—Limited Edition

Updated Category News Views 14

The Buzz Behind Bucked Up®'s Limited-Edition Flavor You know, there's caffeine, and then there's Bucked Up®'s caffeine kick—it’s a whole different animal. But now they’ve spiced things up a notch with their new Hunt: Orange Cream flavor. It’s plastered on every product from their line, from Bucked Up® to the wacky-named Woke AF®. Feels like they’re saying,...

Continue Reading
Transform Your Investment: The Growth of SPS Commerce Over Time

Updated Category News Views 53

The Impressive Growth of SPS Commerce SPS Commerce (NASDAQ: SPSC) has carved out a strong position in the market, consistently providing remarkable returns. Over the last 15 years, this company has outpaced average market growth by a staggering 13.26% each year, resulting in an average annual return of 25.11%. As of now, SPS Commerce enjoys a robust market capitalization...

Continue Reading
Exploring QIAGEN's Commitment to Newborn Genomic Sequencing

Updated Category News Views 106

Innovating Genomic Sequencing for Newborns QIAGEN (NYSE: QGEN) is making significant strides in the field of genomic medicine by partnering with Genomics England on a remarkable initiative aimed at sequencing the genomes of newborns. This pioneering effort seeks to screen for over 200 genetic conditions, facilitating early diagnosis and intervention for rare health...

Continue Reading